Episode 234 -- July 2025 -- Part 2 AFP: Ameri...

Interventions for smokeless tobacco (1:20), ear pain (3:10), testosterone replacement therapy (6:10), cognitive behavior therapy (11:00), respiratory syncytial virus vaccines (13:40), and attention-deficit/hyperactivity disorder treatments (15:30). 

PCSK9 inhibitors (1:50), treatment of opiate use disorder (4:20), healthy dietary advice (6:20), the top 20 research studies of 2025 (11:40), atopic dermatitis prevention (15:10), and ambient temperature increase impact on pregnancy outcomes (17:10). Please fill out our listener ...  Show more

We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-c ...